Ribavirin antiviral combination therapy in COVID 19, a single-center experience
Singh, B. O.; Chikara, G.; Panda, P. K.; Bahurupi, Y. A.; Saha, S.; Pai, V. S.
Show abstract
BackgroundCOVID 19 infection has a similar clinical spectrum of disease presentation such as SARS and MERS in the past. These led to the assumption of the possibility to treat COVID 19 infection with antivirals which had been used to treat SARS and MERS. MethodsA retrospective analysis was done on the data of SEV COVID Trial in symptomatic adult patients of COVID 19 infection with objectives to explore whether ribavirin antiviral combinations reduces the need of both noninvasive and invasive ventilators in treatment of COVID 19 infections. ResultsThe patients were categorized as "Cohort A" consisting of 40 patients and "Cohort B" of 61 patients as Cohort A being the group of patients who received the standard therapy and Cohort B the group of patients who received the ribavirin combination therapy. ConclusionThe study concluded that there was no statistically significant difference in regard to the need of noninvasive ventilation and invasive ventilation and also the development of multi-organ dysfunction in between the two Cohorts. Also, with progress of time, the proportion of patients with single organ dysfunctions in the two cohorts showed gradual recovery without any statistically significant differences.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impact of vaccination and risk factors on COVID-19 mortality amid delta wave in Libya: a single centre cohort study 97%
- Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context 97%
- Laboratory Biomarkers of COVID-19 Disease Severity and Outcome: Findings from a Developing Country 96%
Similar papers in this journal
- Comparative study between first and second wave of COVID-19 deaths in India - a single center study 97%
- Clearing the fog: Is Hydroxychloroquine effective in reducing Corona virus disease-2019 progression: A randomized controlled trial 97%
- Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving the Partial Pressure of Arterial Oxygen and Fraction of Inspired Oxygen Ratio among COVID-19 Patients 96%
Similar papers in this journal
- Evaluation of the disease outcome in Covid-19 infected patients by disease symptoms: a retrospective cross-sectional study in Ilam Province, Iran 97%
- Determinants of Developing Symptomatic Disease in Ethiopian COVID-19 Patients 96%
- Anti-Hepatitis C Antibody Carriage and Risk of Liver Impairment in Rural-Cameroon: Adapting the Control of Hepatocellular Carcinoma for Resource-Limited Settings 94%
Similar papers in this journal
- Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities 97%
- Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case control study 95%
- Mutational spectra of SARS-CoV-2 orf1ab polyprotein and Signature mutations in the United States of America 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.